Our research is concentrated on three primary areas: (1) engineering immune cells, (2) innovating in gene therapy, and (3) developing novel synthetic biology tools and high-throughput genetic screening platforms.
To bring innovation to immune cell engineering and gene therapy, we will develop and employ cutting-edge synthetic biology tools and high-throughput genetic screening platforms. Our ultimate long-term goal is to integrate both areas to develop novel therapies